Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6).

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/004982500237848PMID 10659953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma

  1998cited by this paper
• The metabolism of coumarins : In; Coumarins: Biology, Applications and mode of action.

  1997cited by this paper
• The structure, function, and regulation of cytochrome P450 2A enzymes.

  1997cited by this paper
• Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.

  1997cited by this paper
• A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes.

  1997cited by this paper
• Competitive inhibition of coumarin 7‐hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP2A6

  1995cited by this paper
• The inhibition of CYP enzymes in mouse and human liver by pilocarpine

  1995cited by this paper
• Expression and alternative splicing of the cytochrome P-450 CYP2A7.

  1995cited by this paper
• Differential effects of mutations in substrate recognition site 1 of cytochrome P450 2C2 on lauric acid and progesterone hydroxylation.

  1994cited by this paper
• Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes.

  1993cited by this paper
• Engineering of cytochrome P450 2B1 specificity. Conversion of an androgen 16 beta-hydroxylase to a 15 alpha-hydroxylase.

  1993cited by this paper
• Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences.

  1992cited by this paper
• Purification and characterization of human liver microsomal cytochrome P-450 2A6.

  1991cited by this paper
• Structural function of residue-209 in coumarin 7-hydroxylase (P450coh). Enzyme-kinetic studies and site-directed mutagenesis.

  1991cited by this paper
• The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.

  1990cited by this paper
• Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse.

  1990cited by this paper
• Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity.

  1990cited by this paper
• Sequence requirements for cytochrome P-450IID1 catalytic activity. A single amino acid change (Ile380 Phe) specifically decreases Vmax of the enzyme for bufuralol but not debrisoquine hydroxylation.

  1990cited by this paper
• Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.

  1989cited by this paper
• Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes.

  1989cited by this paper
• Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue

  1989cited by this paper
• Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice.

  1988cited by this paper
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper
• Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice.

  1985cited by this paper
• Structural gene products of the Ah locus. Evidence for many unique P-450-mediated monooxygenase activities reconstituted from 3-methylcholanthrene-treated C57BL/6N mouse liver microsomes.

  1981cited by this paper
• A simple and sensitive assay of 7-ethoxycoumarin deethylation.

  1978cited by this paper

• Redox Metabolomics of Menthol in Children’s Plasma with Second-Hand Cigarette and Electronic Cigarette Exposures

  2025cites this paper
• An Inventory of Methods for the Assessment of Additive Increased Addictiveness of Tobacco Products

  2016cites this paper
• Inhibitory effects and oxidation of 6-methylcoumarin, 7-methylcoumarin and 7-formylcoumarin via human CYP2A6 and its mouse and pig orthologous enzymes

  2016cites this paper
• How can we Improve on Modeling Nicotine Addiction to Develop Better Smoking Cessation Treatments?

  2016cites this paper
• Celery extract inhibits mouse CYP2A5 and human CYP2A6 activities via different mechanisms.

  2016cites this paper
• Rational design of novel CYP2A6 inhibitors.

  2014cites this paper
• ECOTOXICITY OF SODIUM ARSENITE ON EISENIA FETIDA

  2013cites this paper
• Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase

  2011cites this paper
• Identification of novel CYP2A6 inhibitors by virtual screening.

  2011cites this paper
• An investigation of nicotine metabolism in mice : the impact of pharmacological inhibition and genetic influences on nicotine pharmacology.

  2010influential citation
• Investigation of binding features: Effects on the interaction between CYP2A6 and inhibitors

  2010cites this paper
• Development of a New Predictive Model for Interactions with Human Cytochrome P450 2A6 Using Pharmacophore Ensemble/Support Vector Machine (PhE/SVM) Approach

  2009cites this paper
• Synthesis and in vitro Activity of Heterocyclic Inhibitors of CYP2A6 and CYP2A13, Two Cytochrome P450 Enzymes Present in the Respiratory Tract

  2009cites this paper
• Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.

  2009cites this paper
• Comparison of Urinary Scents of Two Related Mouse Species, Mus spicilegus and Mus domesticus

  2009cites this paper
• Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo

  2008influential citation
• Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme—an in silico approach

  2008cites this paper
• Pharmacological and chemical effects of cigarette additives.

  2007cites this paper
• Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6.

  2006cites this paper
• Characterization of humanized liver from chimeric mice using coumarin as a human CYP2A6 and mouse CYP2A5 probe.

  2006cites this paper
• Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.

  2005cites this paper
• Development of models for cytochrome P450 2A5 as well as two of its mutants.

  2005cites this paper
• Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.

  2005cites this paper
• Species differences in CYP enzymes

  2004cites this paper
• Study of inhibition of CYP2A6 by some drugs derived from quinoline

  2003cites this paper
• Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes.

  2003cites this paper
• More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde

  2003cites this paper
• In vitro biotransformation of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine by mouse liver microsomes

  2002cites this paper
• Cytochrome P450 isoform-specific in vitro methods to predict drug metabolism and interactions

  2001cites this paper
• IN VITRO INHIBITION OF CYTOCHROME P 450 ENZYMES IN HUMAN LIVER MICROSOMES BY A POTENT CYP 2 A 6 INHIBITOR , TRANS-2-PHENYLCYCLOPROPYLAMINE ( TRANYLCYPROMINE ) , AND ITS NONAMINE ANALOG

  2001cites this paper
• A comparative molecular field analysis of cytochrome P450 2A5 and 2A6 inhibitors

  2001cites this paper
• In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.

  2001cites this paper
• Celery extract inhibits mouse CYP 2 A 5 and human CYP 2 A 6 activities via different mechanisms

  year unknowncites this paper